PharmaDiagnostics

About:

PharmaDiagnostics engages in the development of analytical techniques to accelerate the drug discovery process. 

Website: http://www.pharmadiagnostics.com

Twitter/X: pharmadx

Top Investors: Capital-E, Allegro Investment Fund, Vinnof

Description:

PharmaDiagnostics NV engages in the development of analytical techniques to accelerate the drug discovery process. The company provides human albumin binding, human orosomucoid, membrane, and redox potential assays, as well as assay systems, which include experimental pKa, experimental log D, P-glycoprotein interaction, Cytochromes P450 interactions, and solubility of new chemical entities in fasted and fed intestinal conditions. It offers assays to the pharmaceutical and biotech industries. The company is based in Zellik, Belgium.

Total Funding Amount:

$7.43M

Headquarters Location:

Zellik, Vlaams-Brabant, Belgium

Founded Date:

2007-01-01

Contact Email:

bvaneesbeeck(AT)pharmadiagnostics.com

Founders:

Patrick Englebienne

Number of Employees:

11-50

Last Funding Date:

2010-01-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai